The highly expressed TRMT112 in the GBM group may promote the formation of the THUMPD3-TRMT112 complex, and increase the methylation modification of tRNA m2G6, thereby increasing the stability of tRNA and reducing the biogenesis of tRF-5s. This evidence concerns the gene THUMPD3 and glioblastoma.